Keyword: Prevail Therapeutics
The dispute centers on whether Asa Abeliovich used Alector’s confidential information in connection with his work for Prevail Therapeutics.
Just before Memorial Day weekend, five biotech companies dropped their IPO plans, adding up to $611 million in anticipated cash.
Xenotransplantation firm eGenesis hires new R&D head; Relay adds execs to chemistry, R&D; and Navidea brings on new CMO focused on imaging.
The biotech will use the funds to advance programs for Parkinson's and other neurodegenerative diseases caused by lysosomal dysfunction.
Biotech VC Jonathan Silverstein has unveiled the next development in his quest to find a cure for Parkinson's with GBA.